Prostate cancer and polymorphism D85Y in gene for dihydrotestosterone degrading enzyme UGT2B15: Frequency of DD homozygotes increases with Gleason Score

Prostate. 2004 Jun 1;59(4):436-9. doi: 10.1002/pros.20024.

Abstract

Background: Although, a functional rationale for influence of polymorphism D85Y in gene UGT2B15 on prostate cancer (PCa) exists (different V(max) of enzyme), conflicting results have been reported.

Methods: DNA from 178 controls and 206 PCa patients with known Gleason score were genotyped using a newly developed RFLP assay, which allowed the detection of both alleles in an individual after single PCR amplification.

Controls: 16% DD, 52% DY; PCa patients: 23% DD, 49% DY. Subgroups of PCa: well differentiated: 11% DD, 37% DY; moderately differentiated: 22% DD, 50% DY; poorly differentiated: 34% DD, 50% DY. Correlation was confirmed between Gleason score and number of D alleles (P = 0.018) and persisted after age adjustment. When comparing controls to patients with a Gleason score of 7 or more, difference for the frequency of homozygosity DD was significant between the groups (P = 0.032, OR = 2.04).

Conclusions: Polymorphism D85Y in gene UGT2B15 correlates with differentiation of PCa.

MeSH terms

  • Aged
  • Case-Control Studies
  • Cell Differentiation
  • Cell Transformation, Neoplastic*
  • Female
  • Genotype
  • Glucuronosyltransferase / genetics*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging*
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Polymorphism, Restriction Fragment Length
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / physiopathology*

Substances

  • Glucuronosyltransferase
  • UDP-glucuronosyltransferase 2B15, human